Taysha Gene Therapies, Inc. (TSHA)
4.245
+0.24
(+5.86%)
USD |
NASDAQ |
Oct 27, 16:00
4.25
0.00 (0.00%)
After-Hours: 19:15
Taysha Gene Therapies Price : 4.245 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 3.98 | 4.09 | 3.95 | 4.01 | 1.820M |
| Oct 23, 2026 | 3.95 | 3.98 | 3.755 | 3.96 | 2.593M |
| Oct 22, 2026 | 4.07 | 4.175 | 3.935 | 4.005 | 3.105M |
| Oct 21, 2026 | 4.15 | 4.265 | 4.05 | 4.12 | 3.511M |
| Oct 20, 2026 | 3.95 | 4.20 | 3.89 | 4.11 | 10.93M |
| Oct 19, 2026 | 3.66 | 3.965 | 3.65 | 3.94 | 5.817M |
| Oct 16, 2026 | 3.73 | 3.745 | 3.60 | 3.62 | 2.752M |
| Oct 15, 2026 | 3.53 | 3.79 | 3.50 | 3.73 | 4.686M |
| Oct 14, 2026 | 3.51 | 3.715 | 3.455 | 3.51 | 4.343M |
| Oct 13, 2026 | 4.09 | 4.13 | 3.55 | 3.58 | 6.117M |
| Oct 12, 2026 | 4.46 | 4.56 | 4.125 | 4.14 | 4.214M |
| Oct 09, 2026 | 4.42 | 4.565 | 4.36 | 4.49 | 5.383M |
| Oct 08, 2026 | 4.37 | 4.455 | 4.325 | 4.43 | 3.915M |
| Oct 07, 2026 | 4.33 | 4.46 | 4.26 | 4.43 | 3.912M |
| Oct 06, 2026 | 4.51 | 4.57 | 4.26 | 4.39 | 4.836M |
| Oct 05, 2026 | 4.64 | 4.64 | 4.37 | 4.49 | 4.975M |
| Oct 02, 2026 | 4.80 | 4.86 | 4.63 | 4.63 | 2.990M |
| Oct 01, 2026 | 4.86 | 4.935 | 4.73 | 4.74 | 3.848M |
| Sep 30, 2026 | 5.03 | 5.03 | 4.82 | 4.87 | 3.902M |
| Sep 29, 2026 | 4.97 | 5.03 | 4.80 | 4.99 | 6.570M |
| Sep 28, 2026 | 4.64 | 5.055 | 4.56 | 4.99 | 6.262M |
| Sep 25, 2026 | 4.88 | 4.88 | 4.665 | 4.67 | 4.661M |
| Sep 24, 2026 | 4.88 | 4.90 | 4.655 | 4.79 | 6.405M |
| Sep 23, 2026 | 5.11 | 5.14 | 4.88 | 4.91 | 5.507M |
| Sep 22, 2026 | 5.11 | 5.215 | 5.082 | 5.16 | 2.306M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 2.04 |
| Protalix Biotherapeutics, Inc. | 2.515 |
| Humacyte, Inc. | 0.4499 |
| Agenus, Inc. | 6.655 |
| Amgen, Inc. | 447.97 |
Price Related Metrics
| PS Ratio | 265.85 |
| PEG Ratio | -0.4656 |
| Price to Book Value | 3.566 |
| Earnings Yield | -10.19% |
| Market Cap | 1.381B |
| PEGY Ratio | -0.4656 |